Willow Biosciences to sell operating subsidiary for $3.38M

https://s43720.pcdn.co/wp-content/uploads/2024/01/willowbiosciences-1280x960.jpeg

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) has reached an agreement to sell its wholly-owned operating subsidiary Epimeron USA, Inc. to an unnamed private UK-based company for US$3.38 million in cash, the company announced Friday.

The Alberta-based biotechnology firm said in a statement that the transaction includes the company’s biotechnology business,…

Please login to read all 344 words.

Leave a Reply

Your email address will not be published. Required fields are marked *